Bullish
This podcast episode discusses Sanofi's Rare Humanitarian Program, which has provided free enzyme replacement therapy for lysosomal storage disorders ...
Neutral
SK Bioscience Co Ltd significantly expanded its partnership with Sanofi in December 2024 to develop and commercialize pneumococcal vaccines, strengthe...
Neutral
Sanofi's recent earnings report, while seemingly lackluster, may be influenced by conservative accounting practices. The company's statutory profit wa...
The FDA has granted Breakthrough Therapy designation to Sanofi's investigational oral drug venglustat for the treatment of neurological issues associa...